Zeba Vanek

1.4k total citations
10 papers, 725 citations indexed

About

Zeba Vanek is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Zeba Vanek has authored 10 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Cognitive Neuroscience. Recurrent topics in Zeba Vanek's work include Parkinson's Disease Mechanisms and Treatments (3 papers), Neurological diseases and metabolism (2 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). Zeba Vanek is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (3 papers), Neurological diseases and metabolism (2 papers) and Botulinum Toxin and Related Neurological Disorders (2 papers). Zeba Vanek collaborates with scholars based in United States and Switzerland. Zeba Vanek's co-authors include Barbara J. Knowlton, Teena D. Moody, Joseph Jankovic, Susan Y. Bookheimer, Verna R. Porter, Edmond Teng, Catherine A. Sugar, Greg M. Cole, John M. Ringman and Vladimir Badmaev and has published in prestigious journals such as Neuropsychologia, Movement Disorders and Behavioral Neuroscience.

In The Last Decade

Zeba Vanek

10 papers receiving 709 citations

Peers

Countries citing papers authored by Zeba Vanek

Since Specialization

Citations

This map shows the geographic impact of Zeba Vanek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zeba Vanek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zeba Vanek more than expected).

Fields of papers citing papers by Zeba Vanek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zeba Vanek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zeba Vanek. The network helps show where Zeba Vanek may publish in the future.

Co-authorship network of co-authors of Zeba Vanek

This figure shows the co-authorship network connecting the top 25 collaborators of Zeba Vanek. A scholar is included among the top collaborators of Zeba Vanek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zeba Vanek. Zeba Vanek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study 2012 ·Alzheimer s Research & Therapy ·John M. Ringman, Sally A. Frautschy, Edmond Teng, Aynun N. Begum, (unknown), Maryam Beigi, Karen H. Gylys, Vladimir Badmaev, Dennis D. Heath, Liana G. Apostolova, Verna R. Porter, Zeba Vanek, Gad A. Marshall, Gerhard Hellemann, Catherine A. Sugar, Donna Masterman, Thomas J. Montine, Jeffrey L. Cummings, Greg M. Cole	394
2	Concurrent discrimination learning in Parkinson’s disease. 2010 ·Behavioral Neuroscience ·Teena D. Moody, (unknown), Zeba Vanek, Barbara J. Knowlton	9
3	Zonisamide for essential tremor: An evaluator‐blinded study 2009 ·Movement Disorders ·Adrian Handforth, Fredricka C. Martin, Gail A. Kang, Zeba Vanek	37
4	P4‐344: Oral curcumin for the treatment of mild‐to‐moderate Alzheimer's disease: Tolerability and clinical and biomarker efficacy results of a placebo‐controlled 24‐week study 2008 ·Alzheimer s & Dementia ·John M. Ringman, Greg M. Cole, Edmond Teng, Vladimir Badmaev, (unknown), Sally A. Frautschy, Emily R. Rosario, (unknown), Verna R. Porter, Zeba Vanek, Catherine A. Sugar, (unknown), Jeffrey L. Cummings	15
5	Creutzfeldt–Jakob disease presenting with alien limb sign 2006 ·Movement Disorders ·Brent L. Fogel, Mark Li‐cheng Wu, Sarah Kremen, (unknown), George R. Jackson, Zeba Vanek	10
6	Backward inhibition in Parkinson's disease 2005 ·Neuropsychologia ·Christina L. Fales, Zeba Vanek, Barbara J. Knowlton	28
7	An Implicit Learning Task Activates Medial Temporal Lobe in Patients With Parkinson's Disease. 2004 ·Behavioral Neuroscience ·Teena D. Moody, Susan Y. Bookheimer, Zeba Vanek, Barbara J. Knowlton	140
8	Diagnosis and treatment of Wilson’s disease 2002 ·Current Neurology and Neuroscience Reports ·Indu Subramanian, Zeba Vanek, Jeff M. Bronstein	19
9	Dystonia in corticobasal degeneration 2001 ·Movement Disorders ·Zeba Vanek, Joseph Jankovic	55
10	Dystonia in corticobasal degeneration. 2000 ·PubMed ·Zeba Vanek, Joseph Jankovic	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact